Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

Updates in Transcatheter Tricuspid Regurgitation Therapies: Where Ar…

Nicholas Amoroso

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Classification, Diagnosis and Management of Pulmonary Hypertension: …

Icahn School of Medicine at Mount Sinai

R. Benza

CardioPulmonary Exercise Test (CPET) Interpretation for Non-Experts

National Jewish Health

L. A Manka

Update on HI-PEITHO - A Landmark Clinical Trial in PE

PERT Consortium 2022

K. Rosenfield

Catheter-Directed Thrombolysis Is the Preferred Approach for the Tre…

PERT Consortium 2022

P. Monteleone

Metabolic Interventions in PAH

Cleveland Clinic Respiratory Institute

A. R Hemnes

What’s New in Pulmonary Hypertension in 2023

Scripps Health

J. Thomas Heywood

Right Heart Failure Secondary to Non-Group 1 PH

Mayo Clinic Pulmonary and Critical Care Educational Series

H. Cajigas

ACC 2023: Clinical Manifestations of Right Ventricular Failure

ACC 2023 Conference Coverage

J. Huston

Pulmonary Manifestations of SLE: An Update

Keck School of Medicine of USC

F. Quismorio

Pulmonary Hypertension in Patients With ILD: Who, Why and How?

Cleveland Clinic Respiratory Institute

K. Highland

Pulmonary Arterial Hypertension: Update on Diagnosis and Management

Sandeep Sahay

Pulmonary Embolism: Risk Stratification and Management

Talal Dahhan

Role of Thrombolysis for Patients With Acute Intermediate-Risk Pulmo…

CHEST 2022 Coverage

B. Dalal

Pericardiocentesis in Pulmonary Hypertension

Chao-Wei Hwang

New Therapies for Pulmonary Venous Hypertension: Updates on the Trea…

Scripps Health

R. C. Mohan

Interventional Treatment Option for CTEPH: Balloon Pulmonary Angiopl…

CHEST 2022 Coverage

G. Heresi

ATS 2023 Insights: Pulmonary Vascular Disease - Clinical Year in Rev…

ATS 2023 Insights

G. Heresi